News Image

Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101

Provided By GlobeNewswire

Last update: May 13, 2025

- BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model -

- The DBA/2 model is highly predictive of sudden unexpected death in epilepsy (SUDEP) -

Read more at globenewswire.com

BRIGHT MINDS BIOSCIENCES INC

NASDAQ:DRUG (6/24/2025, 8:00:00 PM)

After market: 26.8 -1.2 (-4.29%)

28

+0.91 (+3.36%)



Find more stocks in the Stock Screener

Follow ChartMill for more